These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5118724)

  • 1. The elimination of free, peptide-bound and protein-bound hydroxyproline into dialysate during peritoneal dialysis in patients with renal failure.
    Kowalewski J; Tomaszewski J; Hanzlik J; Zawislak H; Zbikowska A
    Clin Chim Acta; 1971 Aug; 34(1):123-6. PubMed ID: 5118724
    [No Abstract]   [Full Text] [Related]  

  • 2. Proteomics in extracorporeal blood purification and peritoneal dialysis.
    Thongboonkerd V
    J Proteomics; 2010 Jan; 73(3):521-6. PubMed ID: 19527805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dialysis-associated bacterial infections].
    Saito A; Watanabe S
    Nihon Rinsho; 1992 Jan; 50 Suppl():744-50. PubMed ID: 1578760
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic studies with 14-C-hydroxyproline in osteopathies of chronic renal failure.
    Constantinides C; Kostamis P; Ktoros D; Malamos B
    Int J Appl Radiat Isot; 1970 Jan; 21(1):21-5. PubMed ID: 5415008
    [No Abstract]   [Full Text] [Related]  

  • 5. The hydroxyproline content of plasma of patients with impaired renal function.
    Hart W; Duursma SA; Visser WJ; Njio LK
    Clin Nephrol; 1975; 4(3):104-8. PubMed ID: 1183097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of furosemide added to peritoneal dialysis fluid on hydroxyproline excretion in dialysate and urine].
    Sucharzewska-Tomczak M; Grzegorzewska A
    Przegl Lek; 1994; 51(7):300-2. PubMed ID: 7871203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Plasma hydroxyproline in chronic renal failure (author's transl)].
    Heidbreder E; Lüke F; Heidland A
    Med Klin; 1976 Nov; 71(45):1945-51. PubMed ID: 995035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Protein loss during maintenance peritoneal dialysis (author's transl)].
    Selgas R; Beberide JM; Villar A; Quevedo E; Rodríguez Carmona A; Gómez P; Sánchez Sicilia L
    Med Clin (Barc); 1982 Jul 1-31; 79(3):114-7. PubMed ID: 7109766
    [No Abstract]   [Full Text] [Related]  

  • 9. [Protein balance in patients treated with intermittent peritoneal dialysis].
    Radovanović L; Lazić N; Dukanović L; Radlović O; Radmilović A; Dragicević P; Busarac D; Ikonomovski J; Vidanović M; Rosić D
    Lijec Vjesn; 1982; 104(11-12):530-1. PubMed ID: 7187481
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanisms for inefficient peritoneal dialysis in acute renal failure associated with heat stress and exercise.
    Nolph KD; Whitcomb ME; Schrier RW
    Ann Intern Med; 1969 Aug; 71(2):317-36. PubMed ID: 5800295
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship between dialysate oxidized protein and peritoneal membrane transport properties in patients on peritoneal dialysis.
    Latcha S; Hong S; Gibbons N; Kohn N; Mattana J
    Nephrol Dial Transplant; 2008 Oct; 23(10):3295-301. PubMed ID: 18443211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The behavior of protein and glucose levels in the blood and the dialyzing fluid during peritoneal dialysis in patients with renal failure.
    Bromberg-Sznek S; Lyczewska J; Vertun B
    Pol Med J; 1967; 6(3):556-62. PubMed ID: 6038077
    [No Abstract]   [Full Text] [Related]  

  • 13. Hydroxyproline fractions in serum and urine of rats during wound healing.
    Nagelschmidt M; Struck H
    Res Exp Med (Berl); 1977 Jul; 170(3):211-5. PubMed ID: 897356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic peritoneal dialysis.
    Tenckhoff H; Blagg CR; Curtis KF; Hickman RO
    Proc Eur Dial Transplant Assoc; 1973; 10(0):363-71. PubMed ID: 4802428
    [No Abstract]   [Full Text] [Related]  

  • 15. Natriuretic peptide and adrenomedullin levels in chronic renal failure and effects of peritoneal dialysis.
    Obineche EN; Pathan JY; Fisher S; Prickett TC; Yandle TG; Frampton CM; Cameron VA; Nicholls MG
    Kidney Int; 2006 Jan; 69(1):152-6. PubMed ID: 16374436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of protein and peptide fractions from the peritoneal dialysate of patients with chronic renal failure on the lipoprotein lipase activity.
    Lutz W
    Acta Med Pol; 1979; 20(2):131-41. PubMed ID: 532698
    [No Abstract]   [Full Text] [Related]  

  • 17. Glycogen content of skeletal muscle in patients with renal failure.
    Bergström J; Hultman E
    Acta Med Scand; 1969 Sep; 186(3):177-81. PubMed ID: 5363493
    [No Abstract]   [Full Text] [Related]  

  • 18. Iminoacidopathy in renal failure.
    Simon NM; Bell NH; Del Greco F
    Arch Intern Med; 1970 Feb; 125(2):299-301. PubMed ID: 5412018
    [No Abstract]   [Full Text] [Related]  

  • 19. Conjugation of aromatic amines in renal failure.
    Young DS; Wootton ID
    Clin Chim Acta; 1968 Nov; 22(3):403-8. PubMed ID: 5696964
    [No Abstract]   [Full Text] [Related]  

  • 20. Ketoconazole kinetics in chronic peritoneal dialysis.
    Johnson RJ; Blair AD; Ahmad S
    Clin Pharmacol Ther; 1985 Mar; 37(3):325-9. PubMed ID: 3971656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.